1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Presentation and fistula angioarchitecture stratified by age of presentation and by patient gender
Age Gender All Subjects n = 25 ≤2 Years Old at Presentation n = 13 >2 Years Old at Presentation n = 12 P Value Males n = 14 Females n = 11 P Value Baseline clinical characteristics Mean age ± SD 4.2 ± 5.3 y 3.6 ± 5.2 y 5.1 ± 5.7 y .51 Median age (range) 1.2 y (1 day to 16 y) 0.62 y (1 day to 14 y) 3.0 y (21 days to 16 y) Male 56% 62% 50% .70 CHF 32% 62% 0% .0016 43% 9.1% .09 Seizures 32% 23% 42% .41 29% 36% 1.0 Current or prior hemorrhage 16% 7.7% 25% .32 7.1% 27% .29 Focal neurologic deficit 24% 31% 8.3% .32 21% 27% 1.0 Median (range) presentation mRS 2.5 (0–5) Any identified comorbidity or risk factor 48% 69% 25% .047 43% 55% .70 Baseline angioarchitecture >1 arteriovenous connection 64% 100% 25% .0001 64% 64% 1.0 >1 brain vascular lesion 32% 31% 33% 1.0 21% 45% .39 Feeding artery aneurysm(s) 8% 0% 17% .22 14% 0% .49 >1 arterial territory involved 52% 85% 17% .0012 57% 45% .70 Any deep venous drainage in any lesion 40% 54% 25% .23 43% 36% 1.0 >1 draining vein from any lesion 48% 38% 58% .43 43% 64% .43 Massive venous sinus dilation 23% 45% 0% .035 36% 0% .046 Any venous sinus dilation 41% 64% 18% .081 57% 9.1% .033 Vein of Galen dilation 26% 42% 9.1% .16 29% 18% .66